Effects of vincristine on cell survival, cell cycle progression, and mitotic accumulation in asynchronously growing Sarcoma 180 cells
- PMID: 6861131
Effects of vincristine on cell survival, cell cycle progression, and mitotic accumulation in asynchronously growing Sarcoma 180 cells
Abstract
The effects of vincristine (VCR) on cell survival, cell cycle progression, DNA synthesis, and metaphase accumulation were studied in relation to drug concentration and drug exposure duration in Sarcoma 180 cells in vitro. VCR was found to affect cells in interphase, producing a transient G2 block at all drug concentrations and drug exposure durations studied. VCR did not affect DNA synthesis directly. Increases in the metaphase index were delayed and always peaked at approximately 8 hr after drug removal, regardless of the duration of drug exposure. Increases in the metaphase index of sufficient magnitude to be commensurate with VCR lethality were observed only with prolonged drug exposure. VCR produced both nuclear fragmentation and polyploidy. The proportion of cells undergoing polyploidy increased progressively with increasing drug exposure duration. Interference with cytokinesis during prolonged VCR exposure may represent a lethal effect of VCR that is separate from its short-term effects. This could serve as the basis for the clinical study of the antitumor effects of prolonged VCR infusions.
Similar articles
-
Schedule dependence of vincristine lethality in Sarcoma 180 cells following partial synchronization with hydroxyurea.Cancer Res. 1983 Aug;43(8):3598-603. Cancer Res. 1983. PMID: 6861132
-
Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.Cancer Res. 1981 Jul;41(7):2728-37. Cancer Res. 1981. PMID: 6166368
-
Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines.J Natl Cancer Inst. 1981 Aug;67(2):437-43. J Natl Cancer Inst. 1981. PMID: 6943380
-
Effect of 7-con-O-methylnogarol on DNA synthesis, survival, and cell cycle progression of Chinese hamster ovary cells.Cancer Res. 1981 Dec;41(12 Pt 1):4981-7. Cancer Res. 1981. PMID: 6458356
-
A critical review of the use of vincristine (VCR) as a tumour cell synchronizing agent in cancer therapy.Cell Tissue Kinet. 1980 May;13(3):327-35. doi: 10.1111/j.1365-2184.1980.tb00471.x. Cell Tissue Kinet. 1980. PMID: 6989508 Review.
Cited by
-
Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors.J Transl Med. 2010 Feb 10;8:14. doi: 10.1186/1479-5876-8-14. J Transl Med. 2010. PMID: 20146790 Free PMC article.
-
I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma.Mol Cancer. 2010 Sep 1;9:228. doi: 10.1186/1476-4598-9-228. Mol Cancer. 2010. PMID: 20809973 Free PMC article.
-
Cisplatin-Resistant Ovarian Cancer Cells Reveal a Polyploid Phenotype with Remarkable Activation of Nuclear Processes.Adv Biomed Res. 2023 Mar 28;12:77. doi: 10.4103/abr.abr_348_21. eCollection 2023. Adv Biomed Res. 2023. PMID: 37200756 Free PMC article.
-
An efficient multiple-exposure analysis of the toxicity of crisnatol, a DNA intercalator in phase II clinical trials.Invest New Drugs. 1992 Apr;10(1):1-15. doi: 10.1007/BF01275471. Invest New Drugs. 1992. PMID: 1607248
-
Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography.Invest New Drugs. 1993 May-Aug;11(2-3):141-50. doi: 10.1007/BF00874148. Invest New Drugs. 1993. PMID: 8262726
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources